Friday, July 10, 2026

Drug profile · INN

desoximetasone

desoximetasone (TOPICORT) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — desoximetasone
US status
approved
Class
Route
TOPICAL
Patents
0
Programs
2
Data quality
0.84

Quick answer

desoximetasone (TOPICORT) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN desoximetasone
Brand TOPICORT
Mechanism Glucocorticoid receptor agonist
Target Glucocorticoid receptor
Route TOPICAL
Formulation SPRAY

Mechanism of action

Glucocorticoid receptor agonist

Primary target: Glucocorticoid receptor

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. MC-MTX.18/AD Phase 3 · Medac Gesellschaft fuer · moderate to severe atopic dermatitis
  2. SOX Chemotherapy Phase 2 · Chinese Academy of · Gastroesophageal Junction Adenocarcinoma

Related & competitor drugs

  1. beclomethasone dipropionate Glucocorticoid receptor agonist
  2. betamethasone acetate Glucocorticoid receptor agonist
  3. betamethasone dipropionate Glucocorticoid receptor agonist
  4. betamethasone valerate Glucocorticoid receptor agonist
  5. budesonide Alimentary tract and metabolism (A07)
  6. clobetasol propionate Glucocorticoid receptor agonist

Frequently asked questions

What is desoximetasone?

desoximetasone (TOPICORT) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for desoximetasone?

TOPICORT is a marketed brand name for desoximetasone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of desoximetasone?

desoximetasone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.